nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Ifosfamide—testicular cancer	0.0715	0.115	CbGbCtD
Nicardipine—CYP3A5—Ifosfamide—testicular cancer	0.0563	0.091	CbGbCtD
Nicardipine—CYP2C8—Ifosfamide—testicular cancer	0.0541	0.0875	CbGbCtD
Nicardipine—CYP2C19—Ifosfamide—testicular cancer	0.0454	0.0734	CbGbCtD
Nicardipine—ADRA1B—vas deferens—testicular cancer	0.0389	0.328	CbGeAlD
Nicardipine—CYP2C9—Ifosfamide—testicular cancer	0.0378	0.061	CbGbCtD
Nicardipine—CYP2B6—Cisplatin—testicular cancer	0.0348	0.0562	CbGbCtD
Nicardipine—CYP2E1—Etoposide—testicular cancer	0.0346	0.0559	CbGbCtD
Nicardipine—ABCB1—Dactinomycin—testicular cancer	0.031	0.0501	CbGbCtD
Nicardipine—CYP3A5—Etoposide—testicular cancer	0.0269	0.0435	CbGbCtD
Nicardipine—CYP2C8—Etoposide—testicular cancer	0.0259	0.0418	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—testicular cancer	0.0233	0.0376	CbGbCtD
Nicardipine—CYP3A4—Ifosfamide—testicular cancer	0.022	0.0355	CbGbCtD
Nicardipine—ABCB1—Vinblastine—testicular cancer	0.0194	0.0314	CbGbCtD
Nicardipine—CYP2C9—Cisplatin—testicular cancer	0.0184	0.0297	CbGbCtD
Nicardipine—CYP2D6—Vinblastine—testicular cancer	0.0183	0.0296	CbGbCtD
Nicardipine—ABCB1—Cisplatin—testicular cancer	0.0178	0.0288	CbGbCtD
Nicardipine—ABCB1—Etoposide—testicular cancer	0.0175	0.0283	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—testicular cancer	0.0119	0.0193	CbGbCtD
Nicardipine—CYP3A4—Vinblastine—testicular cancer	0.0116	0.0188	CbGbCtD
Nicardipine—ABCB1—Methotrexate—testicular cancer	0.0116	0.0187	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—testicular cancer	0.0113	0.0182	CbGbCtD
Nicardipine—CYP3A4—Etoposide—testicular cancer	0.0105	0.0169	CbGbCtD
Nicardipine—CALM2—semen—testicular cancer	0.00831	0.0699	CbGeAlD
Nicardipine—CALM1—semen—testicular cancer	0.00827	0.0696	CbGeAlD
Nicardipine—CYP3A4—Doxorubicin—testicular cancer	0.00716	0.0116	CbGbCtD
Nicardipine—PDE1B—gonad—testicular cancer	0.00388	0.0327	CbGeAlD
Nicardipine—PDE1A—gonad—testicular cancer	0.00325	0.0274	CbGeAlD
Nicardipine—PDE1B—testis—testicular cancer	0.0028	0.0235	CbGeAlD
Nicardipine—PDE1A—female gonad—testicular cancer	0.00264	0.0222	CbGeAlD
Nicardipine—PDE1A—testis—testicular cancer	0.00234	0.0197	CbGeAlD
Nicardipine—CALM3—seminal vesicle—testicular cancer	0.00224	0.0189	CbGeAlD
Nicardipine—CHRM4—testis—testicular cancer	0.00214	0.018	CbGeAlD
Nicardipine—PDE1B—lymph node—testicular cancer	0.00203	0.0171	CbGeAlD
Nicardipine—CALM2—embryo—testicular cancer	0.00187	0.0158	CbGeAlD
Nicardipine—CALM1—embryo—testicular cancer	0.00187	0.0157	CbGeAlD
Nicardipine—CACNA2D1—female gonad—testicular cancer	0.00183	0.0154	CbGeAlD
Nicardipine—CALM2—seminal vesicle—testicular cancer	0.00176	0.0148	CbGeAlD
Nicardipine—CACNB2—testis—testicular cancer	0.00173	0.0145	CbGeAlD
Nicardipine—PDE1A—lymph node—testicular cancer	0.0017	0.0143	CbGeAlD
Nicardipine—CACNA2D1—testis—testicular cancer	0.00162	0.0137	CbGeAlD
Nicardipine—CACNA1D—testis—testicular cancer	0.00151	0.0127	CbGeAlD
Nicardipine—CACNA1C—testis—testicular cancer	0.00139	0.0117	CbGeAlD
Nicardipine—CALM3—female gonad—testicular cancer	0.00132	0.0111	CbGeAlD
Nicardipine—CALM2—gonad—testicular cancer	0.00127	0.0107	CbGeAlD
Nicardipine—CALM1—gonad—testicular cancer	0.00127	0.0107	CbGeAlD
Nicardipine—CACNB2—lymph node—testicular cancer	0.00125	0.0105	CbGeAlD
Nicardipine—CYP2E1—seminal vesicle—testicular cancer	0.00123	0.0103	CbGeAlD
Nicardipine—CACNA2D1—lymph node—testicular cancer	0.00118	0.0099	CbGeAlD
Nicardipine—CALM3—testis—testicular cancer	0.00117	0.00983	CbGeAlD
Nicardipine—CACNA1D—lymph node—testicular cancer	0.00109	0.00921	CbGeAlD
Nicardipine—CHRM3—female gonad—testicular cancer	0.00106	0.00889	CbGeAlD
Nicardipine—CALM2—female gonad—testicular cancer	0.00103	0.0087	CbGeAlD
Nicardipine—CALM1—female gonad—testicular cancer	0.00103	0.00866	CbGeAlD
Nicardipine—CACNA1C—lymph node—testicular cancer	0.00101	0.00851	CbGeAlD
Nicardipine—CYP2B6—gonad—testicular cancer	0.000946	0.00796	CbGeAlD
Nicardipine—CHRM3—testis—testicular cancer	0.000937	0.00789	CbGeAlD
Nicardipine—CALM2—testis—testicular cancer	0.000917	0.00772	CbGeAlD
Nicardipine—CALM1—testis—testicular cancer	0.000913	0.00768	CbGeAlD
Nicardipine—CALM3—lymph node—testicular cancer	0.000846	0.00712	CbGeAlD
Nicardipine—CYP3A5—female gonad—testicular cancer	0.000773	0.00651	CbGeAlD
Nicardipine—CYP2C8—testis—testicular cancer	0.00076	0.0064	CbGeAlD
Nicardipine—ABCB1—embryo—testicular cancer	0.000745	0.00627	CbGeAlD
Nicardipine—ABCB1—seminal vesicle—testicular cancer	0.0007	0.00589	CbGeAlD
Nicardipine—CYP2B6—testis—testicular cancer	0.000682	0.00574	CbGeAlD
Nicardipine—CALM2—lymph node—testicular cancer	0.000665	0.00559	CbGeAlD
Nicardipine—CALM1—lymph node—testicular cancer	0.000662	0.00557	CbGeAlD
Nicardipine—CYP2E1—testis—testicular cancer	0.00064	0.00539	CbGeAlD
Nicardipine—CYP2D6—female gonad—testicular cancer	0.000571	0.00481	CbGeAlD
Nicardipine—CYP2D6—testis—testicular cancer	0.000507	0.00426	CbGeAlD
Nicardipine—ABCB1—gonad—testicular cancer	0.000506	0.00426	CbGeAlD
Nicardipine—Paraesthesia—Ifosfamide—testicular cancer	0.000417	0.00221	CcSEcCtD
Nicardipine—Ill-defined disorder—Etoposide—testicular cancer	0.000417	0.00221	CcSEcCtD
Nicardipine—Anxiety—Cisplatin—testicular cancer	0.000416	0.00221	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000414	0.0022	CcSEcCtD
Nicardipine—Dyspnoea—Ifosfamide—testicular cancer	0.000414	0.00219	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—testicular cancer	0.000414	0.00219	CcSEcCtD
Nicardipine—Somnolence—Ifosfamide—testicular cancer	0.000413	0.00219	CcSEcCtD
Nicardipine—Discomfort—Cisplatin—testicular cancer	0.000413	0.00219	CcSEcCtD
Nicardipine—ABCB1—female gonad—testicular cancer	0.000411	0.00346	CbGeAlD
Nicardipine—Menopausal symptoms—Doxorubicin—testicular cancer	0.00041	0.00217	CcSEcCtD
Nicardipine—Vomiting—Vinblastine—testicular cancer	0.000409	0.00217	CcSEcCtD
Nicardipine—Malaise—Etoposide—testicular cancer	0.000405	0.00215	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—testicular cancer	0.000404	0.00214	CcSEcCtD
Nicardipine—Vertigo—Etoposide—testicular cancer	0.000404	0.00214	CcSEcCtD
Nicardipine—Headache—Vinblastine—testicular cancer	0.000403	0.00214	CcSEcCtD
Nicardipine—Body temperature increased—Dactinomycin—testicular cancer	0.000401	0.00212	CcSEcCtD
Nicardipine—Abdominal pain—Dactinomycin—testicular cancer	0.000401	0.00212	CcSEcCtD
Nicardipine—Oedema—Cisplatin—testicular cancer	0.0004	0.00212	CcSEcCtD
Nicardipine—Hypersensitivity—Bleomycin—testicular cancer	0.0004	0.00212	CcSEcCtD
Nicardipine—Infection—Cisplatin—testicular cancer	0.000398	0.00211	CcSEcCtD
Nicardipine—Pain—Ifosfamide—testicular cancer	0.000397	0.0021	CcSEcCtD
Nicardipine—Constipation—Ifosfamide—testicular cancer	0.000397	0.0021	CcSEcCtD
Nicardipine—Loss of consciousness—Etoposide—testicular cancer	0.000395	0.00209	CcSEcCtD
Nicardipine—Thrombocytopenia—Cisplatin—testicular cancer	0.000392	0.00208	CcSEcCtD
Nicardipine—Tachycardia—Cisplatin—testicular cancer	0.000391	0.00207	CcSEcCtD
Nicardipine—Asthenia—Bleomycin—testicular cancer	0.00039	0.00207	CcSEcCtD
Nicardipine—Hypertension—Etoposide—testicular cancer	0.000388	0.00206	CcSEcCtD
Nicardipine—Hyperhidrosis—Cisplatin—testicular cancer	0.000387	0.00205	CcSEcCtD
Nicardipine—Feeling abnormal—Ifosfamide—testicular cancer	0.000383	0.00203	CcSEcCtD
Nicardipine—Chest pain—Etoposide—testicular cancer	0.000383	0.00203	CcSEcCtD
Nicardipine—Nausea—Vinblastine—testicular cancer	0.000382	0.00202	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000382	0.00202	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—testicular cancer	0.000381	0.00202	CcSEcCtD
Nicardipine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00038	0.00201	CcSEcCtD
Nicardipine—Discomfort—Etoposide—testicular cancer	0.000378	0.002	CcSEcCtD
Nicardipine—Hypotension—Cisplatin—testicular cancer	0.000374	0.00198	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—testicular cancer	0.000374	0.00198	CcSEcCtD
Nicardipine—Hypersensitivity—Dactinomycin—testicular cancer	0.000373	0.00198	CcSEcCtD
Nicardipine—Confusional state—Etoposide—testicular cancer	0.00037	0.00196	CcSEcCtD
Nicardipine—Abdominal pain—Ifosfamide—testicular cancer	0.000367	0.00195	CcSEcCtD
Nicardipine—Body temperature increased—Ifosfamide—testicular cancer	0.000367	0.00195	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000365	0.00193	CcSEcCtD
Nicardipine—ABCB1—testis—testicular cancer	0.000364	0.00307	CbGeAlD
Nicardipine—Infection—Etoposide—testicular cancer	0.000364	0.00193	CcSEcCtD
Nicardipine—Asthenia—Dactinomycin—testicular cancer	0.000364	0.00193	CcSEcCtD
Nicardipine—Paraesthesia—Cisplatin—testicular cancer	0.000359	0.0019	CcSEcCtD
Nicardipine—Thrombocytopenia—Etoposide—testicular cancer	0.000359	0.0019	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—testicular cancer	0.000358	0.0019	CcSEcCtD
Nicardipine—Dyspnoea—Cisplatin—testicular cancer	0.000357	0.00189	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—testicular cancer	0.000356	0.00189	CcSEcCtD
Nicardipine—Hyperhidrosis—Etoposide—testicular cancer	0.000354	0.00188	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000353	0.00187	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—testicular cancer	0.000352	0.00187	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—testicular cancer	0.000352	0.00187	CcSEcCtD
Nicardipine—Diarrhoea—Dactinomycin—testicular cancer	0.000347	0.00184	CcSEcCtD
Nicardipine—Vomiting—Bleomycin—testicular cancer	0.000345	0.00183	CcSEcCtD
Nicardipine—Hypotension—Etoposide—testicular cancer	0.000343	0.00182	CcSEcCtD
Nicardipine—Rash—Bleomycin—testicular cancer	0.000343	0.00182	CcSEcCtD
Nicardipine—Pain—Cisplatin—testicular cancer	0.000342	0.00181	CcSEcCtD
Nicardipine—Dermatitis—Bleomycin—testicular cancer	0.000342	0.00181	CcSEcCtD
Nicardipine—Hypersensitivity—Ifosfamide—testicular cancer	0.000342	0.00181	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—testicular cancer	0.000335	0.00177	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—testicular cancer	0.000334	0.00177	CcSEcCtD
Nicardipine—Asthenia—Ifosfamide—testicular cancer	0.000333	0.00177	CcSEcCtD
Nicardipine—Sweating—Methotrexate—testicular cancer	0.00033	0.00175	CcSEcCtD
Nicardipine—Feeling abnormal—Cisplatin—testicular cancer	0.00033	0.00175	CcSEcCtD
Nicardipine—Paraesthesia—Etoposide—testicular cancer	0.000329	0.00174	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—testicular cancer	0.000328	0.00174	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—testicular cancer	0.000327	0.00173	CcSEcCtD
Nicardipine—Somnolence—Etoposide—testicular cancer	0.000326	0.00173	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—testicular cancer	0.000326	0.00173	CcSEcCtD
Nicardipine—Nausea—Bleomycin—testicular cancer	0.000323	0.00171	CcSEcCtD
Nicardipine—Vomiting—Dactinomycin—testicular cancer	0.000322	0.00171	CcSEcCtD
Nicardipine—Rash—Dactinomycin—testicular cancer	0.000319	0.00169	CcSEcCtD
Nicardipine—Diarrhoea—Ifosfamide—testicular cancer	0.000318	0.00168	CcSEcCtD
Nicardipine—Body temperature increased—Cisplatin—testicular cancer	0.000316	0.00168	CcSEcCtD
Nicardipine—Constipation—Etoposide—testicular cancer	0.000314	0.00166	CcSEcCtD
Nicardipine—Pain—Etoposide—testicular cancer	0.000314	0.00166	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—testicular cancer	0.000313	0.00166	CcSEcCtD
Nicardipine—Sweating—Epirubicin—testicular cancer	0.000309	0.00164	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—testicular cancer	0.000309	0.00164	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—testicular cancer	0.000307	0.00163	CcSEcCtD
Nicardipine—Dizziness—Ifosfamide—testicular cancer	0.000307	0.00163	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—testicular cancer	0.000302	0.0016	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—testicular cancer	0.000302	0.0016	CcSEcCtD
Nicardipine—Nausea—Dactinomycin—testicular cancer	0.000301	0.00159	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—testicular cancer	0.0003	0.00159	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—testicular cancer	0.000298	0.00158	CcSEcCtD
Nicardipine—Vomiting—Ifosfamide—testicular cancer	0.000295	0.00156	CcSEcCtD
Nicardipine—Hypersensitivity—Cisplatin—testicular cancer	0.000295	0.00156	CcSEcCtD
Nicardipine—Rash—Ifosfamide—testicular cancer	0.000293	0.00155	CcSEcCtD
Nicardipine—Dermatitis—Ifosfamide—testicular cancer	0.000292	0.00155	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—testicular cancer	0.00029	0.00154	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—testicular cancer	0.00029	0.00154	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—testicular cancer	0.00029	0.00154	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—testicular cancer	0.00029	0.00154	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—testicular cancer	0.000288	0.00153	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—testicular cancer	0.000288	0.00153	CcSEcCtD
Nicardipine—Asthenia—Cisplatin—testicular cancer	0.000287	0.00152	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—testicular cancer	0.000286	0.00152	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—testicular cancer	0.000285	0.00151	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—testicular cancer	0.000284	0.00151	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—testicular cancer	0.00028	0.00148	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—testicular cancer	0.000279	0.00148	CcSEcCtD
Nicardipine—Nausea—Ifosfamide—testicular cancer	0.000276	0.00146	CcSEcCtD
Nicardipine—Diarrhoea—Cisplatin—testicular cancer	0.000274	0.00145	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—testicular cancer	0.00027	0.00143	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—testicular cancer	0.00027	0.00143	CcSEcCtD
Nicardipine—Flushing—Epirubicin—testicular cancer	0.000269	0.00142	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—testicular cancer	0.000268	0.00142	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000266	0.00141	CcSEcCtD
Nicardipine—ABCB1—lymph node—testicular cancer	0.000264	0.00222	CbGeAlD
Nicardipine—Oedema peripheral—Doxorubicin—testicular cancer	0.000264	0.0014	CcSEcCtD
Nicardipine—Asthenia—Etoposide—testicular cancer	0.000263	0.00139	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—testicular cancer	0.000258	0.00137	CcSEcCtD
Nicardipine—Vomiting—Cisplatin—testicular cancer	0.000254	0.00135	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—testicular cancer	0.000254	0.00134	CcSEcCtD
Nicardipine—Rash—Cisplatin—testicular cancer	0.000252	0.00134	CcSEcCtD
Nicardipine—Dermatitis—Cisplatin—testicular cancer	0.000252	0.00134	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—testicular cancer	0.000251	0.00133	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—testicular cancer	0.00025	0.00132	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—testicular cancer	0.00025	0.00132	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—testicular cancer	0.000248	0.00132	CcSEcCtD
Nicardipine—Tension—Epirubicin—testicular cancer	0.000247	0.00131	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—testicular cancer	0.000245	0.0013	CcSEcCtD
Nicardipine—Malaise—Methotrexate—testicular cancer	0.000243	0.00129	CcSEcCtD
Nicardipine—Dizziness—Etoposide—testicular cancer	0.000242	0.00129	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—testicular cancer	0.000242	0.00128	CcSEcCtD
Nicardipine—Nausea—Cisplatin—testicular cancer	0.000238	0.00126	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—testicular cancer	0.000237	0.00126	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—testicular cancer	0.000234	0.00124	CcSEcCtD
Nicardipine—Vomiting—Etoposide—testicular cancer	0.000233	0.00124	CcSEcCtD
Nicardipine—Agitation—Epirubicin—testicular cancer	0.000231	0.00123	CcSEcCtD
Nicardipine—Rash—Etoposide—testicular cancer	0.000231	0.00123	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—testicular cancer	0.000231	0.00122	CcSEcCtD
Nicardipine—Headache—Etoposide—testicular cancer	0.00023	0.00122	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—testicular cancer	0.000229	0.00121	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—testicular cancer	0.000229	0.00121	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—testicular cancer	0.000229	0.00121	CcSEcCtD
Nicardipine—Tension—Doxorubicin—testicular cancer	0.000229	0.00121	CcSEcCtD
Nicardipine—Malaise—Epirubicin—testicular cancer	0.000227	0.0012	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—testicular cancer	0.000226	0.0012	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—testicular cancer	0.000226	0.0012	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—testicular cancer	0.000226	0.0012	CcSEcCtD
Nicardipine—Syncope—Epirubicin—testicular cancer	0.000226	0.0012	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—testicular cancer	0.000223	0.00118	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—testicular cancer	0.000221	0.00117	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—testicular cancer	0.000221	0.00117	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—testicular cancer	0.00022	0.00116	CcSEcCtD
Nicardipine—Infection—Methotrexate—testicular cancer	0.000218	0.00116	CcSEcCtD
Nicardipine—Nausea—Etoposide—testicular cancer	0.000218	0.00115	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—testicular cancer	0.000217	0.00115	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000216	0.00115	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—testicular cancer	0.000215	0.00114	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—testicular cancer	0.000214	0.00114	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—testicular cancer	0.000214	0.00114	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—testicular cancer	0.000214	0.00114	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—testicular cancer	0.000214	0.00113	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—testicular cancer	0.000214	0.00113	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—testicular cancer	0.000212	0.00113	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—testicular cancer	0.000212	0.00112	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—testicular cancer	0.00021	0.00111	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—testicular cancer	0.00021	0.00111	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—testicular cancer	0.000209	0.00111	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—testicular cancer	0.000209	0.00111	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—testicular cancer	0.000207	0.0011	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—testicular cancer	0.000206	0.00109	CcSEcCtD
Nicardipine—Oedema—Epirubicin—testicular cancer	0.000206	0.00109	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—testicular cancer	0.000205	0.00109	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—testicular cancer	0.000205	0.00109	CcSEcCtD
Nicardipine—Infection—Epirubicin—testicular cancer	0.000204	0.00108	CcSEcCtD
Nicardipine—Shock—Epirubicin—testicular cancer	0.000202	0.00107	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—testicular cancer	0.000201	0.00107	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—testicular cancer	0.000201	0.00107	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—testicular cancer	0.000201	0.00106	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.0002	0.00106	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—testicular cancer	0.000199	0.00105	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—testicular cancer	0.000199	0.00105	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—testicular cancer	0.000198	0.00105	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—testicular cancer	0.000198	0.00105	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—testicular cancer	0.000198	0.00105	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—testicular cancer	0.000198	0.00105	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—testicular cancer	0.000197	0.00105	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—testicular cancer	0.000196	0.00104	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—testicular cancer	0.000196	0.00104	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—testicular cancer	0.000195	0.00103	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—testicular cancer	0.000194	0.00103	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—testicular cancer	0.000193	0.00102	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—testicular cancer	0.000192	0.00102	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—testicular cancer	0.000192	0.00102	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—testicular cancer	0.00019	0.00101	CcSEcCtD
Nicardipine—Infection—Doxorubicin—testicular cancer	0.000189	0.001	CcSEcCtD
Nicardipine—Pain—Methotrexate—testicular cancer	0.000188	0.000995	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000187	0.000992	CcSEcCtD
Nicardipine—Shock—Doxorubicin—testicular cancer	0.000187	0.000992	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000186	0.000987	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—testicular cancer	0.000186	0.000985	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—testicular cancer	0.000186	0.000984	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—testicular cancer	0.000185	0.000978	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000184	0.000974	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—testicular cancer	0.000183	0.000971	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—testicular cancer	0.000183	0.000968	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—testicular cancer	0.000181	0.000959	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—testicular cancer	0.000181	0.000959	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00018	0.000952	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—testicular cancer	0.000178	0.000942	CcSEcCtD
Nicardipine—Pain—Epirubicin—testicular cancer	0.000176	0.000932	CcSEcCtD
Nicardipine—Constipation—Epirubicin—testicular cancer	0.000176	0.000932	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—testicular cancer	0.000174	0.00092	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—testicular cancer	0.000174	0.00092	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000173	0.000918	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—testicular cancer	0.000172	0.000912	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—testicular cancer	0.000171	0.000905	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—testicular cancer	0.00017	0.000899	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—testicular cancer	0.000169	0.000898	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—testicular cancer	0.000169	0.000896	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000168	0.000891	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—testicular cancer	0.000167	0.000887	CcSEcCtD
Nicardipine—Pain—Doxorubicin—testicular cancer	0.000163	0.000862	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—testicular cancer	0.000163	0.000862	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—testicular cancer	0.000162	0.000861	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—testicular cancer	0.000162	0.000861	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—testicular cancer	0.000162	0.000858	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—testicular cancer	0.000158	0.000835	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—testicular cancer	0.000157	0.000831	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000156	0.000824	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—testicular cancer	0.000151	0.000803	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—testicular cancer	0.00015	0.000797	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—testicular cancer	0.00015	0.000797	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—testicular cancer	0.00015	0.000796	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—testicular cancer	0.000147	0.000782	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—testicular cancer	0.000145	0.00077	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—testicular cancer	0.000141	0.000745	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—testicular cancer	0.00014	0.000743	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—testicular cancer	0.00014	0.00074	CcSEcCtD
Nicardipine—Rash—Methotrexate—testicular cancer	0.000138	0.000734	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—testicular cancer	0.000138	0.000733	CcSEcCtD
Nicardipine—Headache—Methotrexate—testicular cancer	0.000138	0.000729	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—testicular cancer	0.000136	0.000723	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—testicular cancer	0.000136	0.00072	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—testicular cancer	0.000131	0.000693	CcSEcCtD
Nicardipine—Nausea—Methotrexate—testicular cancer	0.00013	0.000691	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—testicular cancer	0.00013	0.00069	CcSEcCtD
Nicardipine—Rash—Epirubicin—testicular cancer	0.00013	0.000687	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—testicular cancer	0.000129	0.000686	CcSEcCtD
Nicardipine—Headache—Epirubicin—testicular cancer	0.000129	0.000682	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—testicular cancer	0.000126	0.000667	CcSEcCtD
Nicardipine—Nausea—Epirubicin—testicular cancer	0.000122	0.000647	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—testicular cancer	0.000121	0.000641	CcSEcCtD
Nicardipine—Rash—Doxorubicin—testicular cancer	0.00012	0.000636	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—testicular cancer	0.00012	0.000635	CcSEcCtD
Nicardipine—Headache—Doxorubicin—testicular cancer	0.000119	0.000631	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—testicular cancer	0.000113	0.000599	CcSEcCtD
Nicardipine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000104	0.00142	CbGpPWpGaD
Nicardipine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000102	0.0014	CbGpPWpGaD
Nicardipine—CALM3—DAP12 interactions—FGFR3—testicular cancer	0.000102	0.0014	CbGpPWpGaD
Nicardipine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000102	0.0014	CbGpPWpGaD
Nicardipine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	0.000102	0.00138	CbGpPWpGaD
Nicardipine—CALM3—Downstream signal transduction—KIT—testicular cancer	0.000101	0.00138	CbGpPWpGaD
Nicardipine—CALM3—Signaling by FGFR—KIT—testicular cancer	0.000101	0.00138	CbGpPWpGaD
Nicardipine—PDE1A—Innate Immune System—KIT—testicular cancer	0.000101	0.00137	CbGpPWpGaD
Nicardipine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000101	0.00137	CbGpPWpGaD
Nicardipine—CALM3—Signaling by ERBB2—KIT—testicular cancer	0.0001	0.00137	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—FGFR3—testicular cancer	0.0001	0.00137	CbGpPWpGaD
Nicardipine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	0.0001	0.00136	CbGpPWpGaD
Nicardipine—CACNB2—Developmental Biology—MMP2—testicular cancer	0.0001	0.00136	CbGpPWpGaD
Nicardipine—CALM3—DAP12 signaling—KIT—testicular cancer	0.0001	0.00136	CbGpPWpGaD
Nicardipine—CALM2—DAP12 interactions—FGFR3—testicular cancer	9.91e-05	0.00135	CbGpPWpGaD
Nicardipine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	9.91e-05	0.00135	CbGpPWpGaD
Nicardipine—CALM1—DAP12 interactions—FGFR3—testicular cancer	9.91e-05	0.00135	CbGpPWpGaD
Nicardipine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	9.91e-05	0.00135	CbGpPWpGaD
Nicardipine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	9.91e-05	0.00135	CbGpPWpGaD
Nicardipine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	9.91e-05	0.00135	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	9.82e-05	0.00134	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	9.82e-05	0.00134	CbGpPWpGaD
Nicardipine—CALM2—Downstream signal transduction—KIT—testicular cancer	9.82e-05	0.00134	CbGpPWpGaD
Nicardipine—CALM1—Downstream signal transduction—KIT—testicular cancer	9.82e-05	0.00134	CbGpPWpGaD
Nicardipine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	9.8e-05	0.00133	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—HPGDS—testicular cancer	9.78e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM1—Signaling by FGFR—KIT—testicular cancer	9.77e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM2—Signaling by FGFR—KIT—testicular cancer	9.77e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	9.74e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	9.74e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM1—Signaling by ERBB2—KIT—testicular cancer	9.72e-05	0.00132	CbGpPWpGaD
Nicardipine—CALM2—Signaling by ERBB2—KIT—testicular cancer	9.72e-05	0.00132	CbGpPWpGaD
Nicardipine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	9.69e-05	0.00132	CbGpPWpGaD
Nicardipine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	9.69e-05	0.00132	CbGpPWpGaD
Nicardipine—CALM2—DAP12 signaling—KIT—testicular cancer	9.67e-05	0.00132	CbGpPWpGaD
Nicardipine—CALM1—DAP12 signaling—KIT—testicular cancer	9.67e-05	0.00132	CbGpPWpGaD
Nicardipine—CALM3—B Cell Activation—FGFR3—testicular cancer	9.48e-05	0.00129	CbGpPWpGaD
Nicardipine—CACNA1D—Developmental Biology—MMP2—testicular cancer	9.47e-05	0.00129	CbGpPWpGaD
Nicardipine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	9.41e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	9.41e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM3—DAP12 interactions—KIT—testicular cancer	9.41e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	9.4e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—KITLG—testicular cancer	9.39e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM3—Signaling by EGFR—KIT—testicular cancer	9.32e-05	0.00127	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—HPGDS—testicular cancer	9.27e-05	0.00126	CbGpPWpGaD
Nicardipine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	9.24e-05	0.00126	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—KIT—testicular cancer	9.22e-05	0.00126	CbGpPWpGaD
Nicardipine—CALM3—Signaling by PDGF—KIT—testicular cancer	9.2e-05	0.00125	CbGpPWpGaD
Nicardipine—CALM1—B Cell Activation—FGFR3—testicular cancer	9.17e-05	0.00125	CbGpPWpGaD
Nicardipine—CALM2—B Cell Activation—FGFR3—testicular cancer	9.17e-05	0.00125	CbGpPWpGaD
Nicardipine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM1—DAP12 interactions—KIT—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM2—DAP12 interactions—KIT—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—INSL3—testicular cancer	9.1e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	9.09e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	9.09e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—KITLG—testicular cancer	9.08e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—KITLG—testicular cancer	9.08e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	9.08e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR—KIT—testicular cancer	9.02e-05	0.00123	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR—KIT—testicular cancer	9.02e-05	0.00123	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	8.94e-05	0.00122	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	8.94e-05	0.00122	CbGpPWpGaD
Nicardipine—CALM2—Signaling by PDGF—KIT—testicular cancer	8.9e-05	0.00121	CbGpPWpGaD
Nicardipine—CALM1—Signaling by PDGF—KIT—testicular cancer	8.9e-05	0.00121	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—BCL10—testicular cancer	8.88e-05	0.00121	CbGpPWpGaD
Nicardipine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	8.78e-05	0.0012	CbGpPWpGaD
Nicardipine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	8.78e-05	0.0012	CbGpPWpGaD
Nicardipine—CALM3—B Cell Activation—KIT—testicular cancer	8.71e-05	0.00119	CbGpPWpGaD
Nicardipine—PDE1A—Disease—H2AFZ—testicular cancer	8.63e-05	0.00118	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—KITLG—testicular cancer	8.6e-05	0.00117	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—BCL10—testicular cancer	8.59e-05	0.00117	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—BCL10—testicular cancer	8.59e-05	0.00117	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—BCL10—testicular cancer	8.53e-05	0.00116	CbGpPWpGaD
Nicardipine—CALM1—B Cell Activation—KIT—testicular cancer	8.42e-05	0.00115	CbGpPWpGaD
Nicardipine—CALM2—B Cell Activation—KIT—testicular cancer	8.42e-05	0.00115	CbGpPWpGaD
Nicardipine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.33e-05	0.00113	CbGpPWpGaD
Nicardipine—CACNA1C—Developmental Biology—MMP2—testicular cancer	8.32e-05	0.00113	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—BCL10—testicular cancer	8.25e-05	0.00112	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—BCL10—testicular cancer	8.25e-05	0.00112	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—INSL3—testicular cancer	8.21e-05	0.00112	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—INSL3—testicular cancer	8.18e-05	0.00111	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—HPGDS—testicular cancer	8.14e-05	0.00111	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—INSL3—testicular cancer	8.1e-05	0.0011	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—INSL3—testicular cancer	8.08e-05	0.0011	CbGpPWpGaD
Nicardipine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.06e-05	0.0011	CbGpPWpGaD
Nicardipine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.06e-05	0.0011	CbGpPWpGaD
Nicardipine—PDE1A—Disease—KITLG—testicular cancer	7.94e-05	0.00108	CbGpPWpGaD
Nicardipine—PDE1B—Disease—H2AFZ—testicular cancer	7.9e-05	0.00108	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—KITLG—testicular cancer	7.87e-05	0.00107	CbGpPWpGaD
Nicardipine—PDE1B—Disease—KITLG—testicular cancer	7.27e-05	0.00099	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—STK11—testicular cancer	7.11e-05	0.000968	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.01e-05	0.000955	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—FGFR3—testicular cancer	6.98e-05	0.000951	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—INSL3—testicular cancer	6.85e-05	0.000933	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—FGFR3—testicular cancer	6.75e-05	0.00092	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—FGFR3—testicular cancer	6.75e-05	0.00092	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—STK11—testicular cancer	6.73e-05	0.000917	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—INSL3—testicular cancer	6.63e-05	0.000902	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—INSL3—testicular cancer	6.63e-05	0.000902	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—KIT—testicular cancer	6.41e-05	0.000873	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—FGFR3—testicular cancer	6.39e-05	0.000871	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.26e-05	0.000852	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—KIT—testicular cancer	6.2e-05	0.000844	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—KIT—testicular cancer	6.2e-05	0.000844	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—H2AFZ—testicular cancer	6.05e-05	0.000824	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—STK11—testicular cancer	6.01e-05	0.000819	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—STK11—testicular cancer	5.92e-05	0.000806	CbGpPWpGaD
Nicardipine—PDE1A—Disease—FGFR3—testicular cancer	5.9e-05	0.000804	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—KIT—testicular cancer	5.87e-05	0.0008	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—FGFR3—testicular cancer	5.85e-05	0.000797	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.7e-05	0.000777	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—KITLG—testicular cancer	5.56e-05	0.000758	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—H2AFZ—testicular cancer	5.53e-05	0.000753	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—STK11—testicular cancer	5.5e-05	0.000749	CbGpPWpGaD
Nicardipine—PDE1A—Disease—KIT—testicular cancer	5.42e-05	0.000738	CbGpPWpGaD
Nicardipine—PDE1B—Disease—FGFR3—testicular cancer	5.4e-05	0.000735	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—KIT—testicular cancer	5.37e-05	0.000731	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—KITLG—testicular cancer	5.36e-05	0.00073	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—KITLG—testicular cancer	5.18e-05	0.000706	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—KITLG—testicular cancer	5.18e-05	0.000706	CbGpPWpGaD
Nicardipine—CALM3—Immune System—BCL10—testicular cancer	5.17e-05	0.000705	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—KITLG—testicular cancer	5.14e-05	0.000701	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—KITLG—testicular cancer	5.09e-05	0.000693	CbGpPWpGaD
Nicardipine—CALM2—Immune System—BCL10—testicular cancer	5.01e-05	0.000682	CbGpPWpGaD
Nicardipine—CALM1—Immune System—BCL10—testicular cancer	5.01e-05	0.000682	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—KITLG—testicular cancer	4.98e-05	0.000678	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—KITLG—testicular cancer	4.98e-05	0.000678	CbGpPWpGaD
Nicardipine—PDE1B—Disease—KIT—testicular cancer	4.96e-05	0.000675	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—HPGDS—testicular cancer	4.29e-05	0.000584	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—FGFR3—testicular cancer	4.13e-05	0.000563	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—FGFR3—testicular cancer	3.98e-05	0.000542	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—H2AFZ—testicular cancer	3.9e-05	0.000531	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—STK11—testicular cancer	3.87e-05	0.000528	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—FGFR3—testicular cancer	3.85e-05	0.000525	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—FGFR3—testicular cancer	3.85e-05	0.000525	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	3.82e-05	0.000521	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—KIT—testicular cancer	3.8e-05	0.000517	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—FGFR3—testicular cancer	3.78e-05	0.000515	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—H2AFZ—testicular cancer	3.73e-05	0.000508	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—STK11—testicular cancer	3.71e-05	0.000505	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	3.7e-05	0.000504	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	3.7e-05	0.000504	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—HPGDS—testicular cancer	3.69e-05	0.000502	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—KIT—testicular cancer	3.66e-05	0.000498	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—HPGDS—testicular cancer	3.61e-05	0.000492	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—HPGDS—testicular cancer	3.6e-05	0.000491	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—HPGDS—testicular cancer	3.59e-05	0.000489	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KITLG—testicular cancer	3.58e-05	0.000488	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—KIT—testicular cancer	3.54e-05	0.000482	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—KIT—testicular cancer	3.54e-05	0.000482	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—KIT—testicular cancer	3.51e-05	0.000478	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—H2AFZ—testicular cancer	3.51e-05	0.000478	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—STK11—testicular cancer	3.49e-05	0.000475	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—KIT—testicular cancer	3.47e-05	0.000473	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—HPGDS—testicular cancer	3.47e-05	0.000473	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—HPGDS—testicular cancer	3.47e-05	0.000473	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KITLG—testicular cancer	3.43e-05	0.000468	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—KIT—testicular cancer	3.4e-05	0.000462	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—KIT—testicular cancer	3.4e-05	0.000462	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KITLG—testicular cancer	3.23e-05	0.00044	CbGpPWpGaD
Nicardipine—CALM3—Disease—H2AFZ—testicular cancer	3.13e-05	0.000426	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—HPGDS—testicular cancer	3.12e-05	0.000425	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KITLG—testicular cancer	3.12e-05	0.000425	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—STK11—testicular cancer	3.11e-05	0.000424	CbGpPWpGaD
Nicardipine—CALM2—Disease—H2AFZ—testicular cancer	3.03e-05	0.000413	CbGpPWpGaD
Nicardipine—CALM1—Disease—H2AFZ—testicular cancer	3.03e-05	0.000413	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KITLG—testicular cancer	3.02e-05	0.000411	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KITLG—testicular cancer	3.02e-05	0.000411	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—H2AFZ—testicular cancer	2.91e-05	0.000397	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STK11—testicular cancer	2.9e-05	0.000394	CbGpPWpGaD
Nicardipine—CALM3—Disease—KITLG—testicular cancer	2.88e-05	0.000392	CbGpPWpGaD
Nicardipine—CALM1—Disease—KITLG—testicular cancer	2.79e-05	0.00038	CbGpPWpGaD
Nicardipine—CALM2—Disease—KITLG—testicular cancer	2.79e-05	0.00038	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—HPGDS—testicular cancer	2.79e-05	0.000379	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—HPGDS—testicular cancer	2.72e-05	0.00037	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—STK11—testicular cancer	2.68e-05	0.000365	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KITLG—testicular cancer	2.68e-05	0.000365	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—FGFR3—testicular cancer	2.66e-05	0.000363	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	2.63e-05	0.000358	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—STK11—testicular cancer	2.62e-05	0.000357	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	2.62e-05	0.000357	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—STK11—testicular cancer	2.62e-05	0.000357	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STK11—testicular cancer	2.61e-05	0.000356	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—STK11—testicular cancer	2.61e-05	0.000355	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STK11—testicular cancer	2.6e-05	0.000355	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	2.59e-05	0.000353	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	2.59e-05	0.000352	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STK11—testicular cancer	2.58e-05	0.000351	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STK11—testicular cancer	2.57e-05	0.00035	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—HPGDS—testicular cancer	2.56e-05	0.000349	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—FGFR3—testicular cancer	2.55e-05	0.000347	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—HPGDS—testicular cancer	2.54e-05	0.000346	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—STK11—testicular cancer	2.52e-05	0.000344	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—STK11—testicular cancer	2.52e-05	0.000344	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KIT—testicular cancer	2.45e-05	0.000333	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KITLG—testicular cancer	2.42e-05	0.000329	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KITLG—testicular cancer	2.41e-05	0.000328	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—FGFR3—testicular cancer	2.4e-05	0.000327	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KITLG—testicular cancer	2.39e-05	0.000325	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KITLG—testicular cancer	2.38e-05	0.000324	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KIT—testicular cancer	2.34e-05	0.000319	CbGpPWpGaD
Nicardipine—CALM3—Immune System—FGFR3—testicular cancer	2.32e-05	0.000316	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—STK11—testicular cancer	2.27e-05	0.000309	CbGpPWpGaD
Nicardipine—CALM1—Immune System—FGFR3—testicular cancer	2.24e-05	0.000306	CbGpPWpGaD
Nicardipine—CALM2—Immune System—FGFR3—testicular cancer	2.24e-05	0.000306	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KIT—testicular cancer	2.2e-05	0.0003	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	2.19e-05	0.000299	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STK11—testicular cancer	2.18e-05	0.000297	CbGpPWpGaD
Nicardipine—CALM3—Disease—FGFR3—testicular cancer	2.14e-05	0.000292	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KIT—testicular cancer	2.13e-05	0.00029	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	2.12e-05	0.000289	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	2.12e-05	0.000289	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STK11—testicular cancer	2.11e-05	0.000287	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STK11—testicular cancer	2.11e-05	0.000287	CbGpPWpGaD
Nicardipine—CALM1—Disease—FGFR3—testicular cancer	2.07e-05	0.000282	CbGpPWpGaD
Nicardipine—CALM2—Disease—FGFR3—testicular cancer	2.07e-05	0.000282	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KIT—testicular cancer	2.06e-05	0.00028	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KIT—testicular cancer	2.06e-05	0.00028	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—STK11—testicular cancer	2.02e-05	0.000276	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KITLG—testicular cancer	2.02e-05	0.000275	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—FGFR3—testicular cancer	1.99e-05	0.000271	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—STK11—testicular cancer	1.98e-05	0.000269	CbGpPWpGaD
Nicardipine—CALM3—Disease—KIT—testicular cancer	1.97e-05	0.000268	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KITLG—testicular cancer	1.95e-05	0.000266	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KITLG—testicular cancer	1.95e-05	0.000266	CbGpPWpGaD
Nicardipine—CALM2—Disease—KIT—testicular cancer	1.9e-05	0.000259	CbGpPWpGaD
Nicardipine—CALM1—Disease—KIT—testicular cancer	1.9e-05	0.000259	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—STK11—testicular cancer	1.86e-05	0.000254	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—STK11—testicular cancer	1.85e-05	0.000251	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KIT—testicular cancer	1.83e-05	0.000249	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—FGFR3—testicular cancer	1.8e-05	0.000245	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—FGFR3—testicular cancer	1.79e-05	0.000244	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—FGFR3—testicular cancer	1.77e-05	0.000242	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	1.77e-05	0.000241	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HPGDS—testicular cancer	1.68e-05	0.000228	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KIT—testicular cancer	1.65e-05	0.000225	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KIT—testicular cancer	1.64e-05	0.000224	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KIT—testicular cancer	1.63e-05	0.000222	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KIT—testicular cancer	1.62e-05	0.000221	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—FGFR3—testicular cancer	1.5e-05	0.000204	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—FGFR3—testicular cancer	1.45e-05	0.000198	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—FGFR3—testicular cancer	1.45e-05	0.000198	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KIT—testicular cancer	1.38e-05	0.000187	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KIT—testicular cancer	1.33e-05	0.000181	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KIT—testicular cancer	1.33e-05	0.000181	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—STK11—testicular cancer	1.22e-05	0.000166	CbGpPWpGaD
